CDKN2B-AS1 and cancer: Concurrently, we observed cell type–specific effects for lung cancer with two variants located in cancer pleiotropic regions (TERT and risk of lung adenocarcinoma and CDKN2BAS1 with risk of lung SCC), indicating distinct etiological processes for these two subtypes.